β-endorphin at the intersection of pain and cancer progression: Preclinical evidence is a research paper published in Neuroscience Letters (2020). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: U01 HL117664
NIBIB NIH HHS
Grant: U18 EB029354
NHLBI NIH HHS
Grant: R01 HL147562
National Institutes of Health
Grant: 1U18EB029354-01
Treating pain in sickle cell disease by means of focused ultrasound neuromodulation
National Institutes of Health
Grant: 3U01HL117664-05S1
Cannabinoid-based therapy and approaches to quantify pain in sickle cell disease
National Institutes of Health
Grant: 3R01HL147562-05S1
Role of mast cell traps in Alzheimer's disease
National Institute of Biomedical Imaging and Bioengineering
National Heart, Lung, and Blood Institute
FWCI
0.38
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals